Despite effective and affordable treatments, fewer than one in four hypertensive patients worldwide achieve adequate blood pressure control. This article examines the diagnostic, therapeutic, and systemic failures driving this persistent gap, and what the clinical community must do to close it. The Silent Epidemic We Cannot Afford to Ignore Hyperte